CHATHAM, N.J., May 27, 2020 /PRNewswire/ -- Acquist Therapeutics, Inc., a biopharmaceutical company committed to new treatment for patients with inflammatory diseases, announced the appointment of two new members to its Board of Directors – Thomas P. Haverty, MD, and John R. Redman, MD.